Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enovis (ENOV) Asset Writedowns and Impairment (2018 - 2025)

Historic Asset Writedowns and Impairment for Enovis (ENOV) over the last 6 years, with Q4 2025 value amounting to $548.4 million.

  • Enovis' Asset Writedowns and Impairment changed N/A to $548.4 million in Q4 2025 from the same period last year, while for Oct 2025 it was $1.1 billion, marking a year-over-year increase of 2015825.38%. This contributed to the annual value of $650.3 million for FY2024, which is N/A changed from last year.
  • As of Q4 2025, Enovis' Asset Writedowns and Impairment stood at $548.4 million.
  • Over the past 5 years, Enovis' Asset Writedowns and Impairment peaked at $644.8 million during Q4 2024, and registered a low of -$67.8 million during Q2 2024.
  • Over the past 3 years, Enovis' median Asset Writedowns and Impairment value was $62.7 million (recorded in 2023), while the average stood at $199.8 million.
  • The largest annual percentage gain for Enovis' Asset Writedowns and Impairment in the last 5 years was 4118.6% (2024), contrasted with its biggest fall of 3050.14% (2024).
  • Quarter analysis of 3 years shows Enovis' Asset Writedowns and Impairment stood at -$52.0 million in 2023, then surged by 1340.12% to $644.8 million in 2024, then dropped by 14.94% to $548.4 million in 2025.
  • Its Asset Writedowns and Impairment was $548.4 million in Q4 2025, compared to $644.8 million in Q4 2024 and -$67.8 million in Q2 2024.